Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
The Swedish Orphan Biovitrum AB's (publ) (Sobi) AGM convened earlier today in Stockholm and voted in favour of the resolutions proposed at the meeting, including: Adoption of the profit and loss...
-
Swedish Orphan Biovitrum AB (publ) (Sobi) today announced its results for the first quarter 2013. Revenues for the quarter totalled MSEK 528.5 (506.7), with continued momentum across the commercial...
-
Swedish Orphan Biovitrum AB (publ) (Sobi) presenterade idag sina resultat för första kvartalet 2013. Intäkterna för kvartalet uppgick till total 528,5 MSEK (506,7), med fortsatt fokus på de operativa...
-
Swedish Orphan Biovitrum AB (Sobi) har utnämnt Mats-Olof Wallin till tillförordnad Finansdirektör (CFO). Wallin - tidigare Finansdirektör för det svenska bioteknikföretaget Biotage AB - har mer än 30...
-
Mats-Olof Wallin has been appointed interim Chief Financial Officer at Swedish Orphan Biovitrum AB (Sobi). Wallin - until recently the CFO of Swedish biotech company Biotage AB (publ.) - brings more...
-
Swedish Orphan Biovitrum AB (Sobi) publicerade idag sin årsredovisning för 2012 på företagets webplats www.sobi.com. Rapporten, med titeln "Skapar värde för patienter, partners och...
-
Swedish Orphan Biovitrum AB (Sobi) today published its Annual Report for 2012, themed "Building value for patients, partners and shareholders", on the company's website, www.sobi.com. The report...
-
Kontakt på Exelixis: Charles Butler Vice President, Investor Relations and Corporate Communications Exelixis, Inc. (650) 837-7277 cbutler@exelixis.com Kontakter på Sobi: Anders Edvell Vice President,...
-
Contact: Charles Butler Vice President, Investor Relations and Corporate Communications Exelixis, Inc. (650) 837-7277 cbutler@exelixis.com Anders Edvell Vice President, Sobi Partner Products,...
-
As previously communicated, the Board of Directors of Swedish Orphan Biovitrum AB (Sobi) has decided to issue additional amounts the current bond loan with a loan frame of SEK 1 billion. The issuance...